急性白血病中的MRD:从急性原细胞白血病中吸取的教训
David Kegyes1,2, Praveena S Thiagarajan3, Gabriel Ghiaur2
1MedFuture Research Center for Advanced Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.
Cancers
|September 28, 2024
概括
使用分子生物学,聚合酶链反应 (PCR) 和下一代测序 (NGS) 检测最小残留疾病 (MRD) 现在是一个可测量的现实. 从急性肌肉细胞白血病 (APL) 管理的见解可以通过准MRD来改善其他急性白血病的结果.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 由于分子生物学技术的进步,最小残留疾病 (MRD) 从概念演变为可测量的现实.
- 急性促细胞白血病 (APL) 开创了使用PCR和NGS的MRD检测和消除策略.
- 从APL中吸取的经验教训为其他急性白血病治疗提供了潜在的改善.
研究的目的:
- 审查MRD在急性白血病管理中的当前应用.
- 探索有助于MRD持续性的生物因素.
- 研究骨髓微环境在MRD中的作用.
主要方法:
- 关于急性白血病MRD检测和治疗的当前文献的综述.
- 分析分子生物学技术,包括PCR和NGS.
- 探索白血病干细胞和骨髓微环境相互作用.
主要成果:
- 现在,MRD已成为急性白血病管理中的可量化标志物.
- APL治疗策略为MRD向治疗提供了一个模型.
- 了解MRD的持久性需要检查白血病干细胞和骨髓位.
结论:
- 监测MRD对于优化急性白血病治疗策略至关重要.
- 进一步研究骨髓微环境在MRD中的作用是有必要的.
- 应用APL衍生的见解可以提高其他急性白血病患者的治疗结果.
更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
13.9K
07:39Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
37
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
